UCP1 and type 1 diabetes mellitus: Elevated vascular permeability has been reported in the skin of STZ-treated rats [45,49], hyperglycemic and hyperinsulinemic UCP1/DTA transgenic mice [50], and in patients with type 1 diabetes [51,52,53].